Evaluation of probiotic yogurt on the prevalence of Clostridium difficile infections

Evaluation of probiotic yogurt on the prevalence of Clostridium difficile infections in patients hospitalized in arak Vali Asr Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016092229915N1

Enrollment

132

Registered

2016-10-11

Start date

2014-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridium Difficile infections.

Interventions

Intervention 1: Intervention group: yoghurt probiotic, 200mg/day/8 day. Intervention 2: Control group: common yughurt, 200mg/day/8 day.

Treatment - Other

Placebo

Intervention group: yoghurt probiotic, 200mg/day/8 day

Control group: common yughurt, 200mg/day/8 day

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: persons older than 65 years old admitted in infectious diseases ward who receive antibiotics; no taking antibiotics in the past two months; signed informed consent to participate; no HIV/AIDS; absence of diarrhea during hospitalization. Exclusion criteria: the patient's unwillingness or inability to enforce orders for the study; discharge before 7 days; need for admission in ICU.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clostridium Difficile. Timepoint: 8 days ( during intervention ). Method of measurement: PCR method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElahe Eghbal

Arak University of Medical Sciences

Rsearch@arakmu.ac.ir+98 86 3417 3638

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026